Shares of West Pharmaceutical Services Inc. WST shed 4.03% to $202.49 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.24% ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its stock performance has been volatile, with annual returns of 66% in 2021, ...

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

West Pharmaceutical Services has a 1-year low of $265.00 and a 1-year high of $413.70. The stock has a market cap of $24.30 billion, a P/E ratio of 49.78, a P/E/G ratio of 19.82 and a beta of 1.01.

West Pharmaceutical Services has a 12 month low of $265.00 and a 12 month high of $413.70. The firm has a fifty day simple moving average of $332.25 and a 200-day simple moving average of $314.42.

Looking at the universe of stocks we cover at Dividend Channel, on 2/7/25, West Pharmaceutical Services, Inc. (Symbol: WST), SouthState Corp (Symbol: SSB), and Pinnacle Financial Partners Inc ...

Aurora Pharmaceutical logo "Our sales team is the backbone of our customer relationships, and this expansion reflects both our business growth and our dedication to providing best-in-class service to ...